Stock Events

Stock Events

Corvus Pharmaceuticals (C17.F) Q3 2025 Earnings

7AugConfirmed

Q3 2024

Q4 2024

Q2 2025

Q3 2025

-0.57

-0.4

-0.23

-0.06

Details

Expected EPS

-0.11417571456

Actual EPS

-0.085632

Surprise EPS

0.03

Surprise Percent

+25%

Description

Corvus Pharmaceuticals (C17.F) has reported earnings of -0.085632 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.